logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-4. Demographic characteristics of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (ii) All clients by country and gender (%)

CountryYear%%Gender GenderGender
MaleFemaleratioknown (n)unknown
Belgium200979214844657
Bulgaria200987137183624
Czech Republic200968332818522
Denmark20097822452960
Germany200980204674950
Estonia2009772336870
Ireland200977243724823
Greece20098615655010
Spain(1) 20088515652922233
France200981194468860
Italy200985156541374
Cyprus2009861466682
Latvia2009:::::
Lithuania2009:::::
Luxembourg2009792143500
Hungary200987136429918
Malta20098516617920
Netherlands200981194116500
Austria20097525358490
Poland(1) 200875253147090
Portugal2009:::::
Romania20098020416863
Slovenia2009812049160
Slovakia20098020419090
Finland20096931219061
Sweden200969312502249
United Kingdom2009732731393900
Croatia20098317577330
Turkey200994615256331
Norway::::::
Total:79214459081467

Notes:

 : Indicates no data available 

 Percentages are of clients whose gender is known (n)   

 (1) Last data available refer to 2008. Data presented are from two different monitoring systems (Pilot project for TDI monitoring and Institute of Psychiatry and Neurology - aggregated data). Caution must be made when interpreting the data as double counting could not be avoid. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — TDI tables V. 1.0-2010. See Table TDI-0 for details on sources. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011